Atlas Trials

The Impact of Genetic Polymorphism on the Echocardiographic Parameters and Cardiac Fibrosis Markers in Response to Empagliflozin Treatment Among Patients With Heart Failure

Clinical trial NCT06503601 · UNKNOWN

Trial details

NCT number
NCT06503601
Sponsor
Ain Shams University
Status
UNKNOWN
Study type
OBSERVATIONAL
Heart Failure
Start date
2023-07-30
Primary completion
2025-07-30
Enrollment
92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.